CLINICAL TRIALS PROFILE FOR HALCION
✉ Email this page to a colleague
All Clinical Trials for HALCION
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT01017926 ↗ | Triazolam Trial In Healthy Subjects To Compare Bioavailability Between Formulations Of Triazolam To Determine Their Bioequivalence In Terms Of Rate And Magnitude Of Absorption | Withdrawn | Investigación Farmacológica y Biofarmacéutica | Phase 1 | 2010-08-01 | The purpose of this study is to compare the bioavailability of two oral formulations of Triazolam in healthy volunteers, in order to determine that they are bioequivalent. |
NCT01017926 ↗ | Triazolam Trial In Healthy Subjects To Compare Bioavailability Between Formulations Of Triazolam To Determine Their Bioequivalence In Terms Of Rate And Magnitude Of Absorption | Withdrawn | Pfizer | Phase 1 | 2010-08-01 | The purpose of this study is to compare the bioavailability of two oral formulations of Triazolam in healthy volunteers, in order to determine that they are bioequivalent. |
NCT02822937 ↗ | Sensitivity of Project: EVO Monitor Cognitive Measurements to Pharmacological Agents | Completed | Akili Interactive Labs, Inc. | N/A | 2016-07-01 | This is a study in adults to assess the sensitivity of Project: EVO Monitor cognitive measurements to two short-acting cognitively active pharmacological agents. The participants will receive a placebo, and two pharmacological agents in a randomized order for three in-clinic study days. During each study day in the clinic, the participants will use Project: EVO Monitor and another cognitive task through the day. |
NCT03246724 ↗ | Oral Versus Intravenous Sedation for Ocular Procedures | Completed | Boston Medical Center | Phase 4 | 2017-10-16 | The purpose of this study is to evaluate patient satisfaction after eye surgery when given a capsule compared to an intravenous (IV) dose of sedation (calming medication). Each subject will be given a capsule and an IV in the hospital before their procedure starts, however they will not know which one is the sedation route. Each subject will have their planned surgical procedure as previously discussed with their doctor. After the procedure is completed, the doctors will complete satisfaction surveys. The subject will also complete a satisfaction survey during their regularly scheduled visit the day after surgery. Once the subject completes this survey, their study participation will be complete. The hypothesis is that there will be no difference in patient satisfaction when given a capsule in comparison to IV sedation. If the results of the study support this hypothesis, a capsule could be used in place of IV sedation. By using a capsule for ocular procedures, both patients and the medical practice would benefit: patient would be able to eat before their procedure, patient costs would be decreased, hospital costs would be reduced, and some of these procedures would be given the option to move to a procedure room (freeing up operating room time for other departments). |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for HALCION
Condition Name
Clinical Trial Locations for HALCION
Trials by Country
Clinical Trial Progress for HALCION
Clinical Trial Phase
Clinical Trial Sponsors for HALCION
Sponsor Name